Kathleen Flaherty
Family · Marietta, GANPI 1265755565
Payments from drug & device makers
Across 129 payments — averaging $23.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Livanova USA, Inc.$994
- Upsher-smith Laboratories LLC$102
- Pfizer$96
- Amgen$94
- UCB, Inc.$82
- plus $656 from 23 others
What the payments were for
- Travel & lodging$61820%
- Food & beverage$2,43380%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 69 | $1,026 |
| Livanova USA, Inc. | 4 | $994 |
| Upsher-smith Laboratories LLC | 6 | $102 |
| Pfizer | 4 | $96 |
| Amgen | 7 | $94 |
| UCB, Inc. | 4 | $82 |
| Teva Pharmaceuticals USA, Inc. | 4 | $75 |
| Biohaven Pharmaceuticals, Inc. | 3 | $62 |
| Acadia Pharmaceuticals Inc | 3 | $53 |
| Johnson & Johnson(2 entities) | 2 | $50 |
| Biogen | 2 | $44 |
| Lilly USA, LLC | 2 | $40 |
| EMD Serono, Inc. | 2 | $36 |
| Argenx US, Inc. | 1 | $28 |
| Catalyst Pharmaceuticals, Inc. | 1 | $27 |
| Neurocrine Biosciences, Inc. | 2 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Banner Life Sciences, LLC | 1 | $19 |
| Grifols USA, LLC | 1 | $19 |
| Octapharma USA, Inc. | 1 | $18 |
| Eisai Inc. | 1 | $17 |
| Neurelis, Inc. | 1 | $17 |
| Bristol Myers Squibb | 1 | $16 |
| AstraZeneca | 1 | $15 |
| GE HealthCare | 1 | $14 |
| Acorda Therapeutics, Inc | 1 | $14 |
| Avion Pharmaceuticals | 1 | $13 |
| Almatica Pharma LLC | 1 | $13 |
| Adamas Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$994
How this compares
$3,051 in reported general payments places this provider in the 85th percentile of 6,258 family providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nurtec OdtRimegepant Sulfate | 31 | $39,269 |
| QuliptaAtogepant | 20 | $23,546 |
| Aimovig AutoinjectorErenumab-Aooe | 27 | $22,919 |
| UbrelvyUbrogepant | 15 | $21,076 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 14 | $12,413 |
| Emgality PenGalcanezumab-Gnlm | 13 | $8,869 |
| Pyridostigmine Bromide | 27 | $7,811 |
| Levetiracetam | 65 | $4,044 |
| Memantine Hcl | 134 | $3,616 |
| Lacosamide | 27 | $3,201 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 53 | $2,119 |
| Pregabalin | 22 | $1,479 |
| Gabapentin | 108 | $1,409 |
| Lamotrigine | 28 | $1,073 |
| Levetiracetam ErLevetiracetam | 21 | $1,011 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieQulipta, Ubrelvy | $1,026 | $44,62235 claims |
| PfizerNurtec Odt | $96 | $39,26931 claims |
| Upsher-smith Laboratories LLCTopiramate | $102 | $83291 claims |
| Almatica Pharma LLCSertraline Hcl | $13 | $5611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,258 family providers in Georgia.
Other family in Marietta
- Allie McAllisterMarietta$299K
- Lori ReedMarietta$106K
- Jennifer MekhoukhMarietta$38K
- Janie DinhMarietta$14K
- Erin EsfahaniMarietta$14K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.